Nisha Rathode (Editor)

Mariano Barbacid

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Name
  
Mariano Barbacid


Mariano Barbacid Publications Authored by Mariano Barbacid

Education
  
Complutense University of Madrid

Similar People
  
Maria Blasco Marhuenda, Eugenio Santos, Manuel Serrano Marugan, Joan Massague Sole, Eladio Vinuela

Mariano Barbacid (born 1949 in Madrid) is a Spanish molecular biochemist who discovered the first oncogene. His discovery was published in the prestigious journal Nature in 1982 in an article titled "A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder-carcinoma oncogene". He spent the following months extending his research, eventually discovering that such oncogene was the mutation of an allele of the Ras subfamily, as well as its activation mechanism.

Contents

Mariano Barbacid httpsaxaprods3amazonawscomaxaarfbc880d0e

In 2003 he proved that the enzyme CDK2, until then believed to be indispensable in cellular division, was not necessary in order for DNA replication to take place.

He completed his higher education in the Universidad Complutense de Madrid, where he studied chemical sciences, and in the United States, where he started as an intern; years later he was appointed director of the National Cancer Institute. He then moved back to his native Spain to lead the newly created CINO (Centro Nacional de Investigaciones Oncológicas).

Mariano Barbacid Mariano Barbacid Si viviramos 150 aos todos moriramos de

His research has been published in journals such as Nature and Nature genetics. Among his most cited research are:

Mariano Barbacid Universitat de Barcelona Scientists Mariano Barbacid and Alfred

  • «A point mutation is responsible for the acquisition of transforming properties by the T24 Human Bladder-Carcinoma Oncogene.» (1982).
  • «Direct mutagenesis of HA-RAS-1 oncogenes by N-Nitroso-N-Methylurea during initiation of mammary carcinogenesis in rats.» (1985).
  • "Ras genes." (1987).
  • "The TRK proto-oncogene encodes a receptor for nerve growth-factor." (1991).
  • "trkC, a new member of the trk family of tyrosine protein-kinases, is a receptor for neutotrophin-3." (1991).
  • "Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors." (2000).
  • "Toll-like Receptor-4 (TLR4) Down-regulates MicroRNA-107, Increasing Macrophage Adhesion via Cyclin-dependent Kinase 6." (2011)

    • Mariano Barbacid CNCER DEBATE ABIERTO Prestigiosos onclogos firman una Carta

    His scientific career has been awarded with prizes such as the Distinguished Young Scientist Award (1983), the King Juan Carlos I Science award (1984), the Rhodes Memorial award (1985) and the Charles Rodolphe Brupbacher (2005). His effort has also been acknowledged with the Great Cross of the Order of 2 May (2011).

    Conferencias ibercaja con mariano barbacid investigador


    Awards

  • King Juan Carlos I Award (Spain, 1984)
  • Rhodes Memorial Award (USA, 1985)
  • Joseph Steiner Award (Switzerland, 1988)
  • IPSEN Prize in neuronal plasticity (Austria, 1994)
  • Charles Rodolphe Brupbacher Cancer Prize (Switzerland, 2005)
  • International Agency for Research on Cancer Medal of Honor (France, 2007)

    • References

    Mariano Barbacid Wikipedia
    (Text) CC BY-SA